Clinical Trial Update: Transdermal Methylphenidate for Cancer-Related Fatigue [NA]

View source ↗

Summary

A clinical trial evaluating methylphenidate delivered via a transdermal patch for cancer-related fatigue in head and neck cancer patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Methylphenidate transdermal patch (methylphenidate)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Head and Neck Cancer | NA | Status: WITHDRAWN